ProfileGDS4718 / 212154_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 28% 77% 27% 43% 42% 51% 28% 52% 33% 32% 40% 36% 53% 39% 47% 49% 54% 36% 53% 40% 46% 37% 51% 37% 51% 42% 39% 35% 23% 37% 65% 54% 37% 66% 60% 32% 52% 38% 85% 38% 40% 84% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.622432
GSM549102patient 115, normal, homogenized [OPG study]4.4730928
GSM549104patient 119, normal, homogenized [OPG study]7.6222377
GSM549108patient 138, normal, homogenized [OPG study]4.4775727
GSM549119patient 077, normal, homogenized [OPG study]5.1298643
GSM549133patient 032, cancer, homogenized [OPG study]5.0446242
GSM549139patient 042, cancer, homogenized [OPG study]5.5774551
GSM549099patient 107, normal, homogenized [OPG study]4.491528
GSM549109patient 139, normal, homogenized [OPG study]5.6248952
GSM549110patient 046, normal, homogenized [OPG study]4.6862333
GSM549114patient 063, normal, homogenized [OPG study]4.5722232
GSM549122patient 082, normal, homogenized [OPG study]4.9871240
GSM549134patient 033, cancer, homogenized [OPG study]4.7980636
GSM549136patient 036, cancer, homogenized [OPG study]5.6353
GSM549140patient 044, cancer, homogenized [OPG study]4.9041539
GSM549111patient 047, normal, homogenized [OPG study]5.3256347
GSM549113patient 057, normal, homogenized [OPG study]5.4075149
GSM549132patient 031, cancer, homogenized [OPG study]5.7187354
GSM549137patient 038, cancer, homogenized [OPG study]4.7623736
GSM549142patient 047, cancer, homogenized [OPG study]5.789153
GSM549100patient 110, normal, homogenized [OPG study]5.0265340
GSM549107patient 135, normal, homogenized [OPG study]5.2569346
GSM549115patient 068, normal, homogenized [OPG study]4.7999937
GSM549116patient 072, normal, homogenized [OPG study]5.5411251
GSM549120patient 078, normal, homogenized [OPG study]4.8328137
GSM549131patient 030, cancer, homogenized [OPG study]5.5117751
GSM549118patient 074, normal, homogenized [OPG study]5.0686542
GSM549129patient 027, cancer, homogenized [OPG study]4.9556339
GSM549123patient 088, normal, homogenized [OPG study]4.7243435
GSM549124patient 006, cancer, homogenized [OPG study]4.3073223
GSM549126patient 015, cancer, homogenized [OPG study]4.8601337
GSM549128patient 025, cancer, homogenized [OPG study]6.5055865
GSM549103patient 117, normal, homogenized [OPG study]5.7773354
GSM549117patient 073, normal, homogenized [OPG study]4.8048237
GSM549138patient 041, cancer, homogenized [OPG study]6.5797266
GSM549141patient 045, cancer, homogenized [OPG study]6.1209660
GSM549130patient 028, cancer, homogenized [OPG study]4.6510832
GSM549101patient 111, normal, homogenized [OPG study]5.6730752
GSM549105patient 128, normal, homogenized [OPG study]4.927338
GSM549106patient 134, normal, homogenized [OPG study]8.6391385
GSM549112patient 048, normal, homogenized [OPG study]4.8920938
GSM549125patient 011, cancer, homogenized [OPG study]4.9907840
GSM549127patient 024, cancer, homogenized [OPG study]8.3147284
GSM549135patient 035, cancer, homogenized [OPG study]5.4150949